This inventor holds 1 USPTO granted patent. Top assignee: Sichuan Keiun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovations of Donghong Li
Introduction
Donghong Li is a notable inventor based in Sichuan, China. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative research and development efforts. His work focuses on compounds that have the potential to address serious health issues, including cancer and viral infections.
Latest Patents
Donghong Li holds a patent for a compound of 4'-thionucleoside, which includes a preparation method, a pharmaceutical composition, and its applications. This invention relates to a novel phosphamide derivative of 4'-thionucleoside. The compound is designed for use in medicines aimed at preventing or treating abnormal cell proliferation diseases, such as tumors or cancers, as well as viral infectious diseases.
Career Highlights
Li is associated with Sichuan Keiun-Biotech Biopharmaceutical Co., Ltd., where he continues to advance his research. His work has garnered attention for its potential impact on medical treatments and therapies. With a focus on innovative solutions, he is dedicated to improving health outcomes through his inventions.
Collaborations
Some of his notable coworkers include Yan Qing and Jingyi Wang. Their collaborative efforts contribute to the ongoing research and development initiatives at their company.
Conclusion
Donghong Li's contributions to the field of biopharmaceuticals exemplify the importance of innovation in addressing critical health challenges. His patent for the 4'-thionucleoside compound highlights his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile